1
项与 Donor-Alloantigen-Reactive Regulatory T Cell Infusion(Rho Federal Systems Division) 相关的临床试验Donor-Alloantigen-Reactive Regulatory T Cell (darTreg) Therapy in Liver Transplantation (RTB-002)
The purpose of this study is look at the safety of:
Taking a specific combination of immunosuppressant drugs after liver transplantation
Receiving one of three different doses of donor-alloantigen-reactive regulatory T cells (darTregs) while taking this specific combination of drugs
100 项与 Donor-Alloantigen-Reactive Regulatory T Cell Infusion(Rho Federal Systems Division) 相关的临床结果
100 项与 Donor-Alloantigen-Reactive Regulatory T Cell Infusion(Rho Federal Systems Division) 相关的转化医学
100 项与 Donor-Alloantigen-Reactive Regulatory T Cell Infusion(Rho Federal Systems Division) 相关的专利(医药)
100 项与 Donor-Alloantigen-Reactive Regulatory T Cell Infusion(Rho Federal Systems Division) 相关的药物交易